Skip to Content

Clindamycin Phosphate Injection

Last Updated: May 25, 2018
Status: Current

Products Affected - Description
    • Cleocin injection, Pfizer, 150 mg/mL, 2 mL ADD-Vantage vial, 25 count, NDC 00009-6582-01
    • Cleocin injection, Pfizer, 150 mg/mL, 4 mL ADD-Vantage vial, 25 count, NDC 00009-3124-03
    • Cleocin injection, Pfizer, 150 mg/mL, 4 mL vial, 25 count, NDC 00009-0775-26
    • Cleocin injection, Pfizer, 150 mg/mL, 6 mL ADD-Vantage vial, 25 count, NDC 00009-3447-03
    • Cleocin injection, Pfizer, 600 mg/50 mL, in 5% dextrose premixed bag, 24 count, NDC 00009-3375-02
    • Cleocin injection, Pfizer, 900 mg/50 mL, in 5% dextrose premixed bag, 24 count, NDC 00009-3382-02
    • Clindamycin phosphate injection, Alvogen, 150 mg/mL, 2 mL ADD-Vantage vial, 25 count, NDC 47781-1619-69
    • Clindamycin phosphate injection, Alvogen, 150 mg/mL, 2 mL ADD-Vantage vial, 25 count, NDC 47781-0462-69
    • Clindamycin phosphate injection, Alvogen, 150 mg/mL, 4 mL ADD-Vantage vial, 25 count, NDC 44781-0463-69
    • Clindamycin phosphate injection, Alvogen, 150 mg/mL, 4 mL ADD-Vantage vial, 25 count, NDC 44781-1620-69
    • Clindamycin phosphate injection, Alvogen, 150 mg/mL, 6 mL ADD-Vantage vial, 25 count, NDC 47781-0464-69
    • Clindamycin phosphate injection, Alvogen, 150 mg/mL, 6 mL ADD-Vantage vial, 25 count, NDC 47781-1621-69
    • Clindamycin phosphate injection, Alvogen, 150 mg/mL, 6 mL vial, 25 count, NDC 44781-0461-68
    • Clindamycin phosphate injection, Fresenius Kabi, 150 mg/mL, 2 mL vial, 25 count, NDC 63323-0282-02
    • Clindamycin phosphate injection, Fresenius Kabi, 150 mg/mL, 4 mL vial, 25 count, NDC 63323-0282-04
    • Clindamycin phosphate injection, Fresenius Kabi, 150 mg/mL, 6 mL vial, 25 count, NDC 63323-0282-06
    • Clindamycin phosphate injection, Fresenius Kabi, 150 mg/mL, 60 mL vial, 1 count, NDC 63323-0282-60
Reason for the Shortage
    • Akorn did not provide a reason for the shortage.
    • Alvogen did not provide a reason for the shortage.
    • Fresenius Kabi did not provide a reason for the shortage.
    • Pfizer has Cleocin available.
    • Sagent had clindamycin on shortage due to manufacturing delays.
    • Sandoz has clindamycin injection available.
Available Products
    • Cleocin injection, Pfizer, 150 mg/mL, 2 mL vial, 25 count, NDC 00009-0870-26
    • Cleocin injection, Pfizer, 150 mg/mL, 6 mL vial, 25 count, NDC 00009-0902-18
    • Cleocin injection, Pfizer, 150 mg/mL, 60 mL bulk vial, 5 count, NDC 00009-0728-09
    • Cleocin injection, Pfizer, 300 mg/50 mL, in 5% dextrose premixed bag, 24 count, NDC 00009-3381-02
    • Clindamycin phosphate injection, Akorn, 300 mg/50 mL, in 5% dextrose premixed bottle, 1 count, NDC 17478-0120-50
    • Clindamycin phosphate injection, Akorn, 600 mg/50 mL, premixed bottle, 1 count, NDC 17478-0121-50
    • Clindamycin phosphate injection, Akorn, 900 mg/50 mL, premixed bottle, 1 count, NDC 17478-0122-50
    • Clindamycin phosphate injection, Alvogen, 150 mg/mL, 2 mL vial, 25 count, NDC 47781-0459-68
    • Clindamycin phosphate injection, Alvogen, 150 mg/mL, 4 mL vial, 25 count, NDC 47781-0460-68
    • Clindamycin phosphate injection, Alvogen, 150 mg/mL, 60 mL bulk vial, 1 count, NDC 47781-0465-70
    • Clindamycin phosphate injection, Sagent, 150 mg/mL, 2 mL vial, 25 count, NDC 25021-0115-02
    • Clindamycin phosphate injection, Sagent, 150 mg/mL, 4 mL vial, 25 count, NDC 25021-0115-04
    • Clindamycin phosphate injection, Sagent, 150 mg/mL, 6 mL vial, 25 count, NDC 25021-0115-06
    • Clindamycin phosphate injection, Sagent, 150 mg/mL, 60 mL bulk vial, 1 count, NDC 25021-0115-51
    • Clindamycin phosphate injection, Sandoz, 300 mg/50 mL, in 5% dextrose premixed container, 24 count, NDC 00781-3288-09
    • Clindamycin phosphate injection, Sandoz, 600 mg/50 mL, in 5% dextrose premixed container, 24 count, NDC 00781-3289-09
    • Clindamycin phosphate injection, Sandoz, 900 mg/50 mL, in 5% dextrose premixed container, 24 count, NDC 00781-3290-09

Estimated Resupply Dates

    • Alvogen has clindamycin 150 mg/mL 2 mL, 4 mL, and 6 mL ADD-Vantage presentations on back order and the company cannot estimate a release date.
    • Pfizer has Cleocin 150 mg/mL 2 mL, 4 mL, and 6 mL ADD-Vantage vials on back order and the company estimates a release date of 2019. Cleocin 150 mg/mL 4 mL vials, 900 mg/50 mL in 5% dextrose premixed bags, and 600 mg/50 mL in 5% dextrose premixed bags are available in limited quantities.
    • Fresenius Kabi has clindamycin 150 mg/mL 2 mL, 4 mL, 6 mL, and 60 mL vials available with an expiration date of <9 months.

Updated

Updated May 25, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Created June 13, 2013 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide